跳至主要内容
临床试验/JPRN-UMIN000048174
JPRN-UMIN000048174尚未招募未知

The efficacy and safety of green tea consumption after colon surgery: A randomized controlled trial - Postoperative green tea trial

Tochigi Medical Center Shimotsuga0 个研究点目标入组 30 人开始时间: 2022年6月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Participants who are unable to provide informed consent or comply with research protocols 2. Participants who are known to have problems with mental health or language ability 3. Participants who are participating in other interventional trials 4. Emergency surgery 5. Multiple organ resection at the time of surgery 6. Extension or closure of an enterostomy at the time of surgery 7. Participants undergoing colostomy or ileostomy 8. Complete obstruction 9. Hypersensitivity or allergy to caffeine or green tea 10. American Society of Anesthesiologists (ASA) IV or V physical status score 11. Alcoholism or drug abuse 12. Regular intake of more than 800 mg of caffeine (8-10 cups of coffee) per day 13. Previous extensive abdominal surgery (excluding appendicectomy, cholecystectomy, hernia repair, or cesarean section) 14. Grade III or higher heart failure (NYHA) 15. Opioid analgesics or steroids greater than 5 mg/day for at least 7 days prior to surgery 16. Long-term use of glucocorticoids or stimulant laxatives 17. Taking antidepressants 18. Severe obesity (BMI > 32) and severe malnutrition (BMI < 15) 19. Hypertensive emergencies (>180/120 mmHg) 20. Pregnancy, lactation, or possible childbirth 21. Liver failure and/or cirrhosis (MELD > 15) 22. Drugs that are substrates or inhibitors of CYP1A2 enzymes (e.g., new quinolone antibacterial agents)

研究者

发起方
Tochigi Medical Center Shimotsuga

相似试验

The efficacy and safety of green tea consumption... | 临床试验